OncoTartis, Inc. logo

OncoTartis, Inc.

1 employees · est. 2009

VS
VoxCell logo

VoxCell

Redefining drug development. Replicating human tissues.

30 employees · est. 2020 · Canada

OncoTartis, Inc. is the older company (2009 vs 2020); VoxCell is the larger of the two.

Side-by-Side Comparison

OncoTartis, Inc. VoxCell
Founded
2009 older 2020
Headquarters
Not tracked yet Canada
Employees
1 30 larger
Industry
Biotechnology, Health Care Biopharma, Biotechnology, Health Care
Funding Stage
Series Unknown Seed
Total Funding
$6.00M $2.02M
Funding Rounds
1 6
Services
Not tracked yet Development of 3D bioprinted tissue models, Collaboration on preclinical drug development projects, Consultation on bioprinting technology applications
Target Customers
Not tracked yet Pharmaceutical companies, Biotechnology firms, Preclinical researchers, Bioprinting technology developers
Taxonomy
Drug Discovery, Cancer Treatment, Tissue-specific Targets, Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitor, Oncology, Private Company, Startup, NAMPT-dependent Cancers, Intellectual Property, Roswell Park Cancer Institute, OT-82, Acute Myeloid Leukemia, IND Submission, Innovation Tissue Engineering, 3D Bioprinting, Biopharma, Drug Development, Vascularization, Cancer, Personalized Medicine, Oncology, Research, Pre-clinical, Biomimetic, Vascularized Cancer Tissue Models, 3D Printing, Bioink
Website
oncotartis.com voxcell.com
OncoTartis, Inc. logo

About OncoTartis, Inc.

OncoTartis, Inc. is a biotechnology startup founded in 2009 and located at the Thomas R. Beecher Innovation Center on Buffalo Niagara Medical Campus. The company's strategic partnership with Roswell Park Cancer Institute, along with its origination from the laboratory of Professor Andrei Gudkov, dem...

VoxCell logo

About VoxCell

VoxCell BioInnovation, founded in 2020 and headquartered in Canada, is innovating within the bioprinting arena. The company's slogan, "Truly Biomimetic: Vascularized Human-Like Cancer Tissue Models," encapsulates its mission to transform tissue engineering specifically for the drug development secto...

We will tell you when either one moves

BounceWatch watches OncoTartis, Inc. and VoxCell for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at OncoTartis, Inc. and VoxCell — by email.

Frequently Asked Questions

OncoTartis, Inc.. VoxCell — Redefining drug development. Replicating human tissues.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
OncoTartis, Inc. has raised $6.00M while VoxCell has raised $2.02M.
OncoTartis, Inc. and VoxCell operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare OncoTartis, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at OncoTartis, Inc. on 11 Sep 2024, and VoxCell on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy